iShares U.S. Pharmaceuticals ETF Rating → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free IHE Stock Alerts $66.33 +0.06 (+0.09%) (As of 05:12 PM ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy2.59Holdings in IHE have an aggregate rating of Moderate Buy based on 261 analyst ratings issued in the past year covering 33 companies (99.3% of the portfolio).IHE Aggregate Price Target$80.5821.48% UpsideHigh Prediction$101.53Average Prediction$80.58Low Prediction$62.08Holdings in IHE have an aggregate price target of $80.58 and a range of $62.08 to $101.53 covering 33 companies (99.3% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 33 IHE Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings25.52%LLYEli Lilly and Company$891.46+0.7%5 of 5 stars2.84$787.53 -11.7%19Analyst ForecastInsider SellingGap Up21.24%JNJJohnson & Johnson$145.65-0.2%5 of 5 stars2.38$174.07 19.5%13Analyst ForecastShort Interest ↑4.89%MRKMerck & Co., Inc.$127.99+0.4%4 of 5 stars2.69$133.00 3.9%13Analyst Forecast4.75%PFEPfizer$27.41+1.6%5 of 5 stars2.40$35.86 30.8%15Analyst Forecast4.48%ZTSZoetis$169.66-0.7%5 of 5 stars3.00$211.75 24.8%7Positive News4.24%RPRXRoyalty Pharma$26.26-1.3%5 of 5 stars2.80$43.00 63.7%5Positive News4.10%CTLTCatalent$55.07-0.3%2 of 5 stars2.18$54.05 -1.9%11Positive News3.96%VTRSViatris$10.05-0.6%1 of 5 stars1.33$11.00 9.5%3Insider Selling3.67%BMYBristol-Myers Squibb$40.81-0.4%5 of 5 stars2.11$60.00 47.0%19Dividend AnnouncementAnalyst Downgrade3.63%ELANElanco Animal Health$18.16-0.4%2 of 5 stars2.57$18.29 0.7%7Positive News2.77%JAZZJazz Pharmaceuticals$112.68-1.6%5 of 5 stars2.86$190.92 69.4%14Positive News2.68%ITCIIntra-Cellular Therapies$75.48+9.6%4 of 5 stars2.91$91.50 21.2%11Analyst ForecastShort Interest ↓News CoveragePositive NewsGap UpHigh Trading Volume2.14%OGNOrganon & Co.$20.355 of 5 stars2.50$22.60 11.1%4Positive News1.49%PRGOPerrigo$25.55-2.6%5 of 5 stars3.00$39.67 55.3%3Positive News1.32%PBHPrestige Consumer Healthcare$64.96+0.2%4 of 5 stars2.50$91.25 40.5%41.17%CORTCorcept Therapeutics$28.15-1.5%5 of 5 stars3.00$44.30 57.4%4Analyst Forecast1.13%AXSMAxsome Therapeutics$76.02+0.0%4 of 5 stars2.92$122.08 60.6%13Short Interest ↑Positive News0.74%ARVNArvinas$24.82-0.5%3 of 5 stars2.88$61.13 146.3%16Short Interest ↓Positive News0.63%AMPHAmphastar Pharmaceuticals$40.05-1.2%5 of 5 stars2.50$66.00 64.8%4Positive News0.58%SUPNSupernus Pharmaceuticals$26.66+2.6%4 of 5 stars3.00$41.00 53.8%1Positive News0.54%PCRXPacira BioSciences$28.19+3.1%5 of 5 stars3.00$47.40 68.1%10Positive News0.53%LGNDLigand Pharmaceuticals$80.54-0.1%5 of 5 stars3.00$116.33 44.4%3Short Interest ↓Positive News0.44%EWTXEdgewise Therapeutics$16.18-6.9%2 of 5 stars3.00$31.20 92.8%5Positive NewsGap Up0.44%COLLCollegium Pharmaceutical$32.15+1.0%4 of 5 stars2.40$40.75 26.7%5Positive News0.40%HRMYHarmony Biosciences$28.89-1.6%4 of 5 stars2.50$40.63 40.6%8Positive News0.40%ANIPANI Pharmaceuticals$60.74-1.7%5 of 5 stars3.00$81.00 33.4%40.35%TARSTarsus Pharmaceuticals$27.28-5.4%2 of 5 stars2.88$50.38 84.7%8Gap Up0.31%AMRXAmneal Pharmaceuticals$6.72-0.4%1 of 5 stars3.00$8.25 22.8%4Short Interest ↑0.31%SAVACassava Sciences$19.51-1.9%4 of 5 stars3.00$131.00 571.5%1Positive News0.24%PLRXPliant Therapeutics$10.71-4.4%4 of 5 stars3.00$45.38 323.7%9Gap Up0.12%TBPHTheravance Biopharma$8.48+0.6%1 of 5 stars3.00$20.50 141.7%2Gap Up0.10%RVNCRevance Therapeutics$2.804 of 5 stars2.50$11.50 310.7%8Positive News0.03%AMLXAmylyx Pharmaceuticals$1.62-1.8%3 of 5 stars2.25$28.67 1,669.5%8Short Interest ↓Positive News This page (NYSEARCA:IHE) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
